Business | |||||||
NEWS | |||||||
Astellas Pharma buys Iveric Bio for $5.9 billion Astellas bought IVERIC for $40.00 per share in cash, for a total equity value of approximately $5.9 billion. Reporting by Baranjot Kaur in Bengaluru; Editing by Kim Coghill.
| |||||||
New program strengthens crop production, food security A new program will revitalize hazelnut, grape, berry and tree-fruit production and increase the competitiveness and resiliency of B.C. farm businesses while supporting food security. "The Perennial Crop Renewal Program is about renewal and ensuring our ...
| |||||||
Renewable energy is here. But how do we store it for the future? The two guests on our show today — Bill David and Serena Cussen — challenged us to think about the future of clean energy storage. They spoke to NPR Short Wave co-host Emily Kwong in Washington D.C. at the 2023 annual meeting for the American Association ...
| |||||||
See more results | Edit this alert |
You have received this email because you have subscribed to Google Alerts. |
Receive this alert as RSS feed |
Send Feedback |
Tidak ada komentar:
Posting Komentar